Biosimilar Development guest expert articles provide industry authorities with an outlet to share their views and insights on emerging trends, challenges, technologies, and best practices. Interested contributors should submit their questions, abstracts, outlines, or completed drafts to the editor for consideration.
By delivering valuable information and ideas to Biosimilar Development readers, industry insiders bring increased visibility and credibility to themselves, their organizations, and issues of importance to them. Guest expert articles provide contributors with unique branding and thought-leadership opportunities via:
Guest expert articles should addresses a significant trend or issue of interest to Biosimilar Development readers, and should provide information that our readers will find useful/actionable. Articles should offer a thoughtful — even provocative — take on the chosen theme, and can combine opinion with fact-based observation and information. Possible angles include:
Authors are typically subject matter experts from companies, associations, consulting and analyst firms, academia, or other organizations.
Guest expert articles should be at least 1,000 words in length (not including headline, references, or author bio). For articles well over 2,000 words, we will work with the author to convert them into multi-part series.
Articles should be submitted in editable Microsoft Word format, with the language set to American English.
Graphic elements photos, illustrations, charts, graphs, etc.) may be included. However, the author will be responsible for securing copyright permission to use any images that are not their (or their firm's) own work. Company logos or images bearing company logos will not be accepted. Images ideally should be submitted in JPEG, GIF, or PNG format, and may be embedded in Word docs. The author should indicate where each image should appear within the text, and provide captions for all images.
Articles should be original and exclusive to Biosimilar Development (and other websites in our network). They should not have run in any print or online publication previously, in any form. They also should not be slated to run in any other publications or online sources.
We have a rolling submission schedule and do not use a traditional editorial calendar, so we can work with authors to set mutually agreeable submission deadlines.
Interested contributors should submit their questions, abstracts, outlines, or completed drafts to the editor for consideration.